Cabozantinib In Advanced Neuroendocrine Tumors
1. Progression-free survival had a hazard ratio of 0.38 (extrapancreatic NETs) and 0.23 (pancreatic NETs) for those treated with cabozantinib...
1. Progression-free survival had a hazard ratio of 0.38 (extrapancreatic NETs) and 0.23 (pancreatic NETs) for those treated with cabozantinib...
1. In a cluster randomized clinical trial, electronic health record (EHR)-based intervention increased the frequency of screening and identifying individuals...
1. A higher body roundness index (BRI) trajectory is associated with an increased risk of cardiovascular disease (CVD). Evidence Rating...
1. A participant with amyotrophic lateral sclerosis (ALS) and severe dysarthria underwent surgical implantation of microelectrode arrays set up to...
1. In this randomized clinical trial, adults with an alcohol use disorder (AUD) receiving either treatment as usual (TAU), clinician-delivered...
1. In this randomized controlled trial, among patients with moderately to severely active ulcerative colitis, tulisokibart, a monoclonal antibody directed...
1. A history of mild traumatic brain injury (TBI) in healthy, middle-aged adults was associated with detectable changes in neuroimaging...
1. In this randomized controlled trial, among patients with mixed hyperlipidemia, plozasiran significantly reduced fasting triglyceride levels compared with placebo....
1. Treatment of desmoid tumours with dual anti-CTLA-4 and anti-PD-1 blockade with ipilimumab and nivolumab resulted in an overall response...
1. Major cardiac events were significantly lower in the OCT-guided group compared to the angiography-guided group. 2. Stroke, bleeding events,...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.